These vials, featuring Stevanato Group’s advanced EZ-fill technology, offer a high-quality ready-to-use (RTU) solution designed to meet the rigorous standards and increasing requirements of the pharmaceutical industry.
Key Features of D2F Glass Vials
Direct-to-Fill Technology:
- D2F glass vials are washed, depyrogenated, packaged in nest & tub formats, and sterilized providing a seamless RTU solution.
- Pharmaceutical companies can integrate these vials directly into their aseptic fill-finish processes.
Optimised for Fill-Finish Lines:
-
Developed in collaboration with leading machine suppliers, D2F vials are compatible with a wide range of fill-finish lines, ensuring easy and quick integration, thus speeding up operations.
Increased Stability & Cost Efficiency:
-
D2F vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling.
This results in improved mechanical durability, lower downtime, and fewer rejections during final inspections, ultimately contributing to more stable and cost-efficient fill-finish operations.
Featured companies
Nipro PharmaPackaging International
Nipro PharmaPackaging is specialized in developing and manufacturing advanced pharma packaging products and complete packaging solutions for early development drugs or the...
Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life...
